![Dan C. Wood](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Dan C.
Wood was the founder of Mesa Verde Ventures LLC (founded in 2006) and IngleWood Ventures (founded in 1999) where he held the titles of Founding General Partner and Chief Financial Officer respectively.
He also held former positions as Acting Chief Executive Officer at Satiogen Pharmaceuticals, Inc. (2010-2014) and Director at Cylene Pharmaceuticals, Inc. and Lineagen, Inc. Mr. Wood received his undergraduate degree from Tufts University in 1977 and his MBA from the University of Connecticut in 1978.
Antiguos cargos conocidos de Dan C. Wood.
Empresas | Cargo | Fin |
---|---|---|
Mesa Verde Ventures LLC
![]() Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Fundador | 01/07/2014 |
LineaGen, Inc.
![]() LineaGen, Inc. Medical/Nursing ServicesHealth Services Lineagen, Inc. provides diagnostic evaluation services. It focuses on genetic disorders such as autism, multiple sclerosis, and chronic obstructive pulmonary diseases. The firm provides FirstStep, which provides physicians with integrated genetic testing, counseling, and developmental screening services. The company was founded by Stephen M. Prescott, Andy Peiffer, Michael S. Paul, Mark F. Leppert, Al R. Harris and Alex S. Lindell in 2006 and is headquartered in Salt Lake City, UT. | Director/Miembro de la Junta | - |
Satiogen Pharmaceuticals, Inc.
![]() Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Director Ejecutivo | - |
IngleWood Ventures
![]() IngleWood Ventures Investment ManagersFinance Founded in 1999, IngleWood Ventures is a venture capital firm located in San Diego, California. | Fundador | - |
Cylene Pharmaceuticals, Inc.
![]() Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Director/Miembro de la Junta | - |
Formación de Dan C. Wood.
Tufts University | Undergraduate Degree |
University of Connecticut | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Cylene Pharmaceuticals, Inc.
![]() Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
IngleWood Ventures
![]() IngleWood Ventures Investment ManagersFinance Founded in 1999, IngleWood Ventures is a venture capital firm located in San Diego, California. | Finance |
Mesa Verde Ventures LLC
![]() Mesa Verde Ventures LLC Investment ManagersFinance Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California. | Finance |
Satiogen Pharmaceuticals, Inc.
![]() Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA. | Commercial Services |
LineaGen, Inc.
![]() LineaGen, Inc. Medical/Nursing ServicesHealth Services Lineagen, Inc. provides diagnostic evaluation services. It focuses on genetic disorders such as autism, multiple sclerosis, and chronic obstructive pulmonary diseases. The firm provides FirstStep, which provides physicians with integrated genetic testing, counseling, and developmental screening services. The company was founded by Stephen M. Prescott, Andy Peiffer, Michael S. Paul, Mark F. Leppert, Al R. Harris and Alex S. Lindell in 2006 and is headquartered in Salt Lake City, UT. | Health Services |
- Bolsa de valores
- Insiders
- Dan C. Wood